ArticleActa oncologica (Stockholm, Sweden)2024
High-dose chemotherapy for patients with stage III breast cancer with homologous recombination deficiency: a discrete choice experiment among healthcare providers.
Joost G E Verbeek et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.